SEC Form 4 · accession 0001144204-16-107739
Cytosorbents Corp · CTSO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael G. Bator
Director
Period of report
Jun 7, 2016
Accepted (ET)
Jun 9, 2016 · 5:14 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001175151
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jun 7, 2016 | P | 3,000 | $4.88 | A | 3,000 | D | |
| Common StockF3 | Jun 7, 2016 | A | 60,000 | $0.00 | A | 63,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F4 | $4.69 | Jun 7, 2016 | A | 12,000 | A | — | Jun 7, 2026 | Common Stock | 12,000 | 12,000 | D |
Explanation of responses
- F1The price in column 4 is a weighted average price. The prices actually paid in this transaction range from $4.86 to $4.90.
- F2The reporting person has provided to the issuer, and the issuer will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range reported.
- F3These shares represent restricted stock units and will be settled into common stock upon vesting upon a "Change In Control" of CytoSorbents Corporation, as defined in the CytoSorbents Corporation 2014 Long-Term Incentive Plan.
- F4Such options were granted pursuant to the CytoSorbents Corporation 2014 Long-Term Incentive Plan, which vest in four equal parts at the end of each calendar quarter beginning June 30, 2016.